A phase 2 study of isatuximab monotherapy in patients with multiple myeloma who are refractory to daratumumab
一项针对达雷妥尤单抗耐药的多发性骨髓瘤患者的伊沙妥昔单抗单药治疗的 II 期研究
期刊:Blood Cancer Journal
影响因子:11.6
doi:10.1038/s41408-021-00478-4
Mikhael, Joseph; Belhadj-Merzoug, Karim; Hulin, Cyrille; Vincent, Laure; Moreau, Philippe; Gasparetto, Cristina; Pour, Ludek; Spicka, Ivan; Vij, Ravi; Zonder, Jeffrey; Atanackovic, Djordje; Gabrail, Nashat; Martin, Thomas G; Perrot, Aurore; Bensfia, Samira; Weng, Qilong; Brillac, Claire; Semiond, Dorothée; Macé, Sandrine; Corzo, Kathryn P; Leleu, Xavier